PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers
- PMID: 35916921
- DOI: 10.1007/s00259-022-05905-7
PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers
Comment on
-
PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [68Ga]Ga-PSMA-617.Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4000-4013. doi: 10.1007/s00259-022-05884-9. Epub 2022 Jun 28. Eur J Nucl Med Mol Imaging. 2022. PMID: 35763056 Free PMC article.
References
-
- Bacich DJ, Pinto JT, Tong WP, Heston WDW. Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase. Mamm Genome. 2001;12(2):117–23. https://doi.org/10.1007/s003350010240 . - DOI - PubMed
-
- Perera M, Papa N, Roberts M, Williams M, Udovicich C, Vela I, et al. Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer-updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysis. Eur Urol. 2020;77(4):403–17. https://doi.org/10.1016/j.eururo.2019.01.049 . - DOI - PubMed
-
- Han S, Woo S, Kim YJ, Suh CH. Impact of (68)Ga-PSMA PET on the management of patients with prostate cancer: a systematic review and meta-analysis. Eur Urol. 2018;74(2):179–90. https://doi.org/10.1016/j.eururo.2018.03.030 . - DOI - PubMed
-
- Carlucci G, Ippisch R, Slavik R, Mishoe A, Blecha J, Zhu S. (68)Ga-PSMA-11 NDA approval: a novel and successful academic partnership. J Nucl Med. 2021;62(2):149–55. https://doi.org/10.2967/jnumed.120.260455 . - DOI - PubMed - PMC
-
- Zhang H, Koumna S, Pouliot F, Beauregard J-M, Kolinsky M. PSMA Theranostics: current landscape and future outlook. Cancers. 2021;13(16):4023. https://doi.org/10.3390/cancers13164023 . - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous